Interference by Allopurinol with a diagnostic test could mislead clinicians to diagnose which condition?

Interference by Allopurinol with a diagnostic test could mislead clinicians to diagnose which condition?

• A. Diabetes Mellitus
• B. Gout
• C. Hyperlipidemia
• D. Tuberculosis

Answer: (C)

The key idea is that medicines can interfere with laboratory tests, producing results that look like a different condition. Allopurinol can affect some enzymatic colorimetric lipid assays, which means it can artificially elevate the reported lipid levels. If a lipid test appears high while the patient is taking allopurinol, a clinician might be led to diagnose hyperlipidemia even if the true lipid levels aren’t elevated. In this context, it’s important to review medications when lab results don’t fit the clinical picture. Tests used to diagnose diabetes rely on glucose measurements, tests for tuberculosis rely on mycobacterial or immune responses, and gout is the condition allopurinol is used to treat—so the potential interference here is specifically with lipid testing, leading to an apparent but artifactual hyperlipidemia.

The key idea is that medicines can interfere with laboratory tests, producing results that look like a different condition. Allopurinol can affect some enzymatic colorimetric lipid assays, which means it can artificially elevate the reported lipid levels. If a lipid test appears high while the patient is taking allopurinol, a clinician might be led to diagnose hyperlipidemia even if the true lipid levels aren’t elevated.

In this context, it’s important to review medications when lab results don’t fit the clinical picture. Tests used to diagnose diabetes rely on glucose measurements, tests for tuberculosis rely on mycobacterial or immune responses, and gout is the condition allopurinol is used to treat—so the potential interference here is specifically with lipid testing, leading to an apparent but artifactual hyperlipidemia.